Beta‑Globin Quantitative Test in UAE | 600 AED | DNA Labs UAE

Executive Summary & Core Metrics

Clinical Laboratory Excellence – DNA Labs UAE

99.9% Diagnostic Sensitivity – ISO 9001:2015 certified processing (Cert: INT/EGQ/2509DA/3139), ensuring every beta‑globin gene quantification meets DHA/MOHAP analytical standards.
VIP Mobile Phlebotomy & Cold-Chain Home Collection – Temperature‑controlled sample transport available daily 8 AM–11 PM. Samples safeguarded in ISO‑validated thermal containers from collection to laboratory accessioning.
Post‑Test Clinical Guidance – Complimentary telephonic interpretation of results by a DHA‑licensed Consultant Medical Geneticist, guiding you through gene dosage implications and next steps.
Insurance Verification – Direct billing confirmation via WhatsApp +971 54 548 8731.

DHA Facility License: 1143 | DNA Labs UAE – UAE PDPL compliant data handling | Federal Decree‑Law No. 4 of 2016 on Medical Liability governs clinical safety.

Test Overview & Methodology

The Beta‑Globin Quantitative Test is a high‑precision molecular assay that measures the copy number or expression level of the beta‑globin gene from peripheral whole blood. It is essential for diagnosing thalassemia syndromes, sickle cell disease carrier status, and monitoring gene‑therapy responses. The assay employs quantitative real‑time PCR (qPCR) with internal copy number controls to deliver accurate, reproducible results.

Parameter	DNA Labs UAE (DHA‑Aligned)	Closest Alternative
Methodology	Quantitative Real‑Time PCR (qPCR) with Internal Copy Number Controls	Standard endpoint PCR only
Turnaround Time	3rd working day via secure email / 24 h phone	5–7 working days
Sample Collection	VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (8 AM–11 PM)	Clinic visit only
Clinical Sensitivity	99.9% (qPCR‑grade quantitative normalization)	95–97%
Included Guidance	Telephonic Post‑Test Clinical Consultation by a DHA‑licensed Consultant Medical Geneticist	Raw report only

Physician Insight & Safety Protocols

“The Beta‑Globin Quantitative Test provides precise gene dosage information essential for diagnosing thalassemia syndromes and guiding gene therapy decisions. Results must always be interpreted alongside hemoglobin electrophoresis, complete blood count, and clinical presentation. A single numeric value does not replace a comprehensive specialist hematology assessment.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403

⚠ Advisory – Medication Continuity

Do not discontinue prescribed medication or adjust iron‑chelation therapy based solely on this test result without consulting your treating physician. Unmonitored changes can lead to severe anemia, iron overload, or other complications.

Safety Exclusion Criteria & Emergency Red Flags

Exclusion: Active hemolytic crisis or recent blood transfusion within 4 weeks – these can distort gene quantification results.
Exclusion: Inadequate sample volume or grossly hemolyzed whole blood – pre‑analytical rejection may occur.
Emergency Red Flag: Sudden severe pallor, dyspnea, or splenic sequestration pain – seek emergency care immediately without waiting for test results.
Emergency Red Flag: Chest pain, priapism, or acute neurological symptoms – call 998 (UAE Ambulance) without delay.

Clinical safety and patient consent are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability.

Patient FAQ & Clinical Guidance

1. What is the Beta‑Globin Quantitative Test and why is it performed?

This molecular assay precisely counts beta‑globin gene copies to detect thalassemia mutations, confirm beta‑thalassemia major, identify carrier status, and monitor gene‑therapy outcomes. It is a cornerstone test for inherited hemoglobin disorders.

2. How is the sample collected and is home phlebotomy available?

A trained phlebotomist collects 2–3 mL of peripheral whole blood in an EDTA tube during a VIP home visit. The sample is immediately placed in an ISO‑certified cold‑chain container (2–8°C) and transported to our DHA‑licensed molecular laboratory. Home collection is available daily from 8 AM to 11 PM.

3. When will I receive my results and can I discuss them with a specialist?

Results are delivered by the 3rd working day via secure email. A complimentary telephonic consultation with a DHA‑licensed Consultant Medical Geneticist is included to interpret your gene dosage value and outline recommended next steps.

4. Does this test replace a complete blood count or hemoglobin electrophoresis?

No. The Beta‑Globin Quantitative Test provides gene‑level information and must be correlated with a complete blood count, hemoglobin electrophoresis, and clinical evaluation for a comprehensive diagnosis.

UAE Regulatory & Data Privacy Adherence

✅ Full Compliance with UAE Health Data Regulations

This test and all associated data handling are conducted in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability. ISO 9001:2015 Certified (Certificate: INT/EGQ/2509DA/3139). DHA/MOHAP standard nomenclature applied throughout.

Clinical & Logistical Metadata

Test Name	Beta‑Globin Quantitative Test
Price (AED)	600
Turnaround Time	3rd working day
Sample Type / Matrix	Peripheral Whole Blood (EDTA)
Methodology Used	Quantitative Real‑Time PCR (qPCR) with Internal Copy Number Controls
ICD-10-CM Code	D56.1, Z13.79, D56.3
LOINC Code	81761‑4
DHA Facility License & Laboratory Address	DHA License: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE